Clinical Trials Logo

Clinical Trial Summary

In this study, a single-center, prospective, self-control, and blind design was adopted.


Clinical Trial Description

It is planned to enroll 100 patients with solid pancreatic masses who are to be diagnosed with contrast-enhanced harmonic endoscopy ultrasonography (CH-EUS) follow by EUS-guided fine-needle aspiration (EUS-FNA). First, all patients will be diagnosed both by the AI-assisted diagnosis system and the endoscopists under CH-EUS; Second, to compare the EUS-FNA under the guidance of the AI-assisted ultrasound diagnosis system and the EUS-FNA under manual identification, patients were randomly assigned to undergo EUS-FNA with or without the guidance of AI-assisted diagnosis system for the first two passes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04607720
Study type Interventional
Source The Third Xiangya Hospital of Central South University
Contact Wang Xiao, MD
Phone +8613974889301
Email wxy20011@163.com
Status Recruiting
Phase N/A
Start date January 1, 2020
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT02936960 - Endoscopic Ultrasound-guided Needle-based Confocal Laser Endomicroscopy in Solid Pancreatic Masses N/A
Completed NCT01795066 - Endoscopic Ultrasound-guided Fine Needle Biopsy With 25-gauge Biopsy Needles for Solid Pancreatic Masses N/A